Etodolac Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction
Condition:   Pain, Acute Interventions:   Drug: Fixed Dose Combination;   Drug: Etodolac;   Drug: Cyclobenzaprine Sponsor:   Apsen Farmaceutica S.A. Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2017 Category: Research Source Type: clinical trials

Etodolac and Post-bleaching Sensitivity
Condition:   Medicaments Substances in Therapeutic Use Interventions:   Drug: Etodolac;   Drug: Placebo Sponsor:   Flavia Pardo Salata Nahsan Completed - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2016 Category: Research Source Type: clinical trials